Skip to main content
. 2022 May 23;10(5):e004644. doi: 10.1136/jitc-2022-004644

Figure 4.

Figure 4

Enhanced survival outcomes, resulting from IDH1R132H inhibition, depend on activity of both CD4+ and CD8+ T-cells. (A) Schematic description of the T-cell depletion treatment regimen. (B) Kaplan-Meier survival curve. *P<0.05, **p<0.002; log-rank test.